The U.S. FDA has just granted VPS a Breakthrough Device Designation for the VP.S Encore™ device.
VP.S Encore™ (previously the ULiSSES™device) Wins Create the Future Grand Prize
Let’s change the organ transplant world.
Why 8 hours is transformational
Unparalleled Portability with
Unparalleled Affordability with
The VP.S Encore™ is a one-time use device with patented technology that perfuses organs and vascularized tissues with oxygen. The entire VP.S Encore™ device costs less than the replacement cartridge of a top competitor.
Unparalleled Ease of Use with
VP.S Encore™ is a game-changer.
The very first organ ever transplanted was placed in a cooler and packed in ice, and that is still how most organs are preserved 65 years later. This is unacceptable. Vascular Perfusion Solutions (VPS®) is working with a team of world-class scientists to perfect VP.S Encore™, a device designed to perfuse and resuscitate tissue, allowing organs to remain viable for more than 8 hours.
Our next round of research
Ask a Question
Here you can read about some of our early investigation and technology development.
Preserving Limbs in 21st Century
For those that are interested in learning more about the state of the art in machine perfusion for kidneys, the following article is available:
Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation - Tingle, SJ - 2019 | Cochrane Library
This paper, authored by the inventor of VP.S ENCORE™, illustrates the advantages of oxygenated perfusion. We are excited to note that the VP.S technology is quite different from what is illustrated in this paper. It is much more efficient, and represents a dramatic improvement in the ability of the device to keep organs and limbs alive. Patent applications are pending.
Novel portable hypothermic pulsatile perfusion preservation technology: Improved viability and function of rodent and canine kidneys